PLGA micro- and nanoparticles loaded into gelatin scaffold for controlled drug release

IEEE Transactions on Nanotechnology

Volumn 11, Issue 3, 2012, Pages 546-553

  Asghar, Waseem ^a   Islam, Muhymin ^a   Wadajkar, Aniket S ^a   Wan, Yuan ^a,b   Ilyas, Azhar ^a   Nguyen, Kytai T ^a,c   Iqbal, Samir M ^a,d  

^a The University of Texas at Arlington   (United States)

^b Nanotechnology Research and Teaching Facility   (United States)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

^d UNIVERSITY OF TEXAS AT ARLINGTON   (United States)

Author keywords

Bovine serum albumin (BSA); controlled drug delivery; cross linker; curcumin; gelatin scaffold constructs; multidrug resistance

Indexed keywords

BOVINE SERUM ALBUMINS; CROSS-LINKERS; CURCUMIN; MULTIDRUG RESISTANCE; SCAFFOLD CONSTRUCTS;

ALDEHYDES; BODY FLUIDS; CONTROLLED DRUG DELIVERY; CROSSLINKING; DRUG PRODUCTS; MAMMALS; NANOPARTICLES; PARTICLE SIZE; SCAFFOLDS;

SCAFFOLDS (BIOLOGY);

EID: 84860861671     PISSN: 1536125X     EISSN: None     Source Type: Journal    
DOI: 10.1109/TNANO.2012.2183004     Document Type: Article

References (31)

1. B. Fisher, N. H. Slack, P. J. Cavanaugh, B. Gardner, and R. G. Ravdin, "Postoperative radiotherapy in the treatment of breast cancer: Results of the NSABP clinical trial," Ann. Surg., vol. AS-172, pp. 711-732, 1970.
2. A. Grisotti, "Immediate reconstruction after partial mastectomy," Operative Tech. Plastic Reconstructive Surg., vol. 1, pp. 1-12, 1994.
3. C. M. Malata, S. A. McIntosh, and A. D. Purushotham, "Immediate breast reconstruction after mastectomy for cancer," Br. J. Surg., vol. 87, pp. 1455-1472, 2000.
4. S. J. Kronowitz, J. A. Feledy, K. K. Hunt, H. M. Kuerer, A. Youssef, C. A. Koutz, and G. L. Robb, "Determining the optimal approach to breast reconstruction after partial mastectomy," Plastic Reconstructive Surg., vol. 117, pp. 1-11, 2006. (Pubitemid 44391535)
5. A. K. Bajaj, P. S. Kon, K. C. Oberg, and D. A. G. Miles, "Aesthetic outcomes in patients undergoing breast conservation therapy for the treatment of localized breast cancer," Plastic Reconstructive Surg., vol. 114, pp. 1442-1449, 2004. (Pubitemid 40361951)
6. M. L. Smith and R. D. Gregory, "Reduction mammaplasty: Its role in breast conservation surgery for early-stage breast cancer," Ann. Plastic Surg., vol. 41, pp. 234-239, 1998. (Pubitemid 28411396)
7. M. C. Manning, K. Patel, and R. T. Borchardt, "Stability of protein pharmaceuticals," Pharm. Res., vol. 6, pp. 903-918, 1989. (Pubitemid 20078439)
8. M. A. Vandelli, M. Romagnoli, A. Monti, M. Gozzi, P. Guerra, F. Rivasi, and F. Forni, "Microwave-treated gelatin microspheres as drug delivery system," J. Controlled Release, vol. 96, pp. 67-84, 2004. (Pubitemid 38438490)
9. F. Shen, Y. L. Cui, L. F. Yang, K. D. Yao, X. H. Dong, W. Y. Jia, and H. D. Shi, "A study on the fabrication of porous chitosan/gelatin network scaffold for tissue engineering," Polymer Int., vol. 49, pp. 1596-1599, 2000.
10. C. H. Chang, H. C. Liu, C. C. Lin, C. H. Chou, and F. H. Lin, "Gelatinchondroitin-hyaluronan tri-copolymer scaffold for cartilage tissue engineering," Biomaterials, vol. 24, pp. 4853-4858, 2003.
11. D. W. Hutmacher, M. Sittinger, and M. V. Risbud, "Scaffold-based tissue engineering: Rationale for computer-aided design and solid free-form fabrication systems," TRENDS Biotechnol., vol. 22, pp. 354-362, 2004. (Pubitemid 38887544)
12. Y. W. Chen, S. H. Chiou, T. T. Wong, H. H. Ku, H. T. Lin, C. F. Chung, S. H. Yen, and C. L. Kao, "Using gelatin scaffold with coated basic fibroblast growth factor as a transfer system for transplantation of human neural stem cells," Transplant Proc., vol. 38, no. 5, pp. 1616-1617, 2006.
13. B. J. Boyd, "Past and future evolution in colloidal drug delivery systems," Expert Opin. Drug Deliv., vol. 5, no. 1, pp. 69-85, 2008. (Pubitemid 351234110)
14. Y. Parajó, I. d'Angelo, A. Horváth, T. Vantus, K. György, A. Welle, M. Garcia-Fuentes, and M. J. Alonso, "PLGA: Poloxamer blendmicro-and nanoparticles as controlled release systems for synthetic proangiogenic factors," Eur. J. Pharm. Sci., vol. 41, no. 5, pp. 644-649, 2010.
15. S. Gelperina, O. Maksimenko, A. Khalansky, L. Vanchugova, E. Shipulo, K. Abbasova, R. Berdiev, S. Wohlfart, N. Chepurnova, and J. Kreuter, "Drug delivery to the brain using surfactant-coated poly (lactide-coglycolide) nanoparticles: Influence of the formulation parameters," Eur. J. Pharm. Biopharm., vol. 74, no. 2, pp. 157-163, Sep. 2009.
16. Z. Wang, W. K. Chui, and P. C. Ho, "Design of a multifunctional PLGA nanoparticulate drug delivery system: Evaluation of its physicochemical properties and anticancer activity to malignant cancer cells," Pharm. Res., vol. 26, pp. 1162-1171, 2009.
17. W. H. De Jong and P. J. A. Borm, "Drug delivery and nanoparticles: Applications and hazards," Int. J. Nanomed., vol. 3, pp. 133-149, 2008. (Pubitemid 352042401)
18. K. Shahani and J. Panyam, "Highly loaded, sustained-release microparticles of curcumin for chemoprevention," J. Pharm. Sci., vol. 100, pp. 2599-2609, Jul. 2011.
19. M. S. Cartiera, E. C. Ferreira, C. Caputo, M. E. Egan, M. J. Caplan, and W. M. Saltzman, "Partial correction of cystic fibrosis defects with PLGA nanoparticles encapsulating curcumin," Molec. Pharmaceutics, vol. 7, pp. 86-93, 2009.
20. G. Szakacs, J. K. Paterson, J. A. Ludwig, C. Booth-Genthe, and M. M. Gottesman, "Targeting multidrug resistance in cancer," Nature Rev. Drug Discovery, vol. 5, pp. 219-234, 2006. (Pubitemid 43336035)
21. L. E. van Vlerken, Z. Duan, M. V. Seiden, and M. M. Amiji, "Modulation of intracellular ceramide using polymeric nanoparticles to overcome multidrug resistance in cancer," Cancer Res., vol. 67, pp. 4843-4850, 2007. (Pubitemid 46910193)
22. H. Thomas and H.M. Coley, "Overcoming multidrug resistance in cancer: An update on the clinical strategy of inhibiting p-glycoprotein," Cancer Control, vol. 10, pp. 159-165, 2003. (Pubitemid 36437822)
23. A. J. DeFail, H. D. Edington, S. Matthews,W. C. C. Lee, and K. G.Marra, "Controlled release of bioactive doxorubicin from microspheres embedded within gelatin scaffolds," J. Biomed. Mater. Res. Part A, vol. 79, pp. 954-962, 2006. (Pubitemid 44920133)
24. M. Nidhin, R. Indumathy, K. J. Sreesam, and B. U. Nair, "Synthesis of iron oxide nanoparticles of narrow size distribution on polysaccharide templates," Bulletin Mater. Sci., vol. 31, pp. 93-96, 2008. (Pubitemid 351391019)
25. P. Couvreur, G. Barratt, E. Fattal, P. Legrand, and C. Vauthier, "Nanocapsule technology: A review," Crit. Rev. Therapeutic Drug Carrier Syst., vol. 19, pp. 99-134, 2002.
26. T. Govender, S. Stolnik, M. C. Garnett, L. Illum, and S. S. Davis, "PLGA nanoparticles prepared by nanoprecipitation: Drug loading and release studies of a water soluble drug," J. Controlled Release, vol. 57, pp. 171-185, 1999. (Pubitemid 29062869)
27. T. Govender, T. Riley, T. Ehtezazi, M. C. Garnett, S. Stolnik, L. Illum, and S. S. Davis, "Defining the drug incorporation properties of PLA-PEG nanoparticles," Int. J. Pharmaceutics, vol. 199, pp. 95-110, 2000. (Pubitemid 30224509)
28. J. Panyam, D.Williams, A. Dash, D. Leslie-Pelecky, and V. Labhasetwar, "Solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles," J. Pharm. Sci., vol. 93, pp. 1804-1814, 2004. (Pubitemid 38823706)
29. K. Shahani and J. Panyam, "Highly loaded, sustained-release microparticles of curcumin for chemoprevention," J. Pharm. Sci., vol. 100, pp. 2599-2609, 2011.
30. T. A. Holland, J. K. V. Tessmar, Y. Tabata, and A. G. Mikos, "Transforming growth factor-[beta] 1 release from oligo (poly (ethylene glycol) fumarate) hydrogels in conditions that model the cartilage wound healing environment," J. Controlled Release, vol. 94, pp. 101-114, 2004. (Pubitemid 37542381)
31. X. Z. Zhang, P. Jo Lewis, and C. C. Chu, "Fabrication and characterization of a smart drug delivery system:Microsphere in hydrogel," Biomaterials, vol. 26, pp. 3299-3309, 2005. (Pubitemid 39647263)